Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02408692 · ClinicalTrials.gov registry record · Phase 4
Emergency Contraception and Body Weight: Pilot Study
A Phase 4 study, sponsored by Oregon Health and Science University.
- Completed
- Registry status
- Phase 4
- Development phase
- 10
- Enrollment target
NCT02408692 is a Phase 4 study that has completed, run by Oregon Health and Science University. The registered enrollment target is 10 participants.
The verdict
NCT02408692, a Phase 4 study, has completed, sponsored by Oregon Health and Science University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 10 participants
- Enrollment target
Study Summary
The purpose of this research study is to determine how body weight changes the drug level of an emergency contraceptive pill containing a hormone called levonorgestrel (LNG). This emergency contraceptive is available to women without a prescription, but has recently been found to not work as well to prevent pregnancies in women of higher body weight. The overall goal of this research is to improve the effectiveness of contraception for women, no matter their weight.
Interventions
- DRUG ECx1
- DRUG ECx2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2015-02 |
| Est. Completion | 2015-08 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02408692
The ClinicalTrials.gov registry entry for NCT02408692 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Oregon Health and Science University, which has 546 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which ECx1 is the first listed.
NCT02408692 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02408692 about?
NCT02408692 is a clinical study titled "Emergency Contraception and Body Weight: Pilot Study". The purpose of this research study is to determine how body weight changes the drug level of an emergency contraceptive pill containing a hormone called levonorgestrel (LNG). This emergency contraceptive is available to women without a prescription, but has recently been found to not work as well to...
What is the current status of trial NCT02408692?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 10 participants. The study started on 2015-02. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02408692?
The interventions under investigation include: ECx1 (DRUG), ECx2 (DRUG).
Who is sponsoring clinical trial NCT02408692?
This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.